Top Markets
Coin of the day
Carmell Therapeutics Corporation Carmell Therapeutics Corporation

Carmell Therapeutics Corporation

CTCX
Peringkat dalam Saham #36666
Carmell Therapeutics Corporation (CTCX) specializes in the creation of... Carmell Therapeutics Corporation (CTCX) specializes in the creation of plasma-based bioactive materials (PBMs) aimed at catalyzing tissue regeneration and repair following injury, illness, or the effects of aging. Their flagship product, CT-101, is a versatile accelerant with a dual focus. For orthopedic and dental applications, it's designed to enhance bone healing in cases such as tibia fractures, foot and ankle fusions, spinal fusions, and also serves as a dental bone graft substitute and bone void filler. Furthermore, CT-101 acts as a tissue healing accelerant, addressing conditions like androgenetic alopecia (pattern baldness) and persistent chronic wounds. Established in 2008, the company operates from its headquarters in Pittsburgh, Pennsylvania.
Harga Saham
$0.117
Terakhir disinkronkan: 2025-04-04
Kapitalisasi Pasar
$2.45M
Perubahan (1 hari)
-13.59%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Carmell Therapeutics Corporation (CTCX)

Kategori

Jumlah saham beredar untuk Carmell Therapeutics Corporation (CTCX)
Jumlah saham beredar per June 2026: 2.48M
Menurut laporan keuangan terbaru dan harga saham Carmell Therapeutics Corporation, jumlah saham beredar saat ini adalah 2.48M. Pada akhir December 2023, perusahaan memiliki 20.77M saham beredar. Jumlah saham beredar biasanya dipengaruhi oleh pemecahan saham dan pembelian kembali saham.
Riwayat saham beredar untuk Carmell Therapeutics Corporation (CTCX) dari 2021 hingga 2026
Saham beredar pada akhir setiap tahun
Tahun Saham Beredar Mengubah
2026 (TTM) 2.48M -88.16%
2024 20.91M 0.64%
2023 20.77M 5.08%
2022 19.77M 0.00%
2021 19.77M 0.00%
Saham beredar untuk perusahaan serupa atau pesaing
Perusahaan Saham Beredar Perbedaan Negara
253.90M 10,157.26%
US
62.19M 2,412.22%
NL
- -
CH
- -
KR
0.00 -100.00%
BE